Clinical Trial Update: Phase 2 Study for the Treatment of Superficial Lipomas [Phase 2]

View source ↗

Summary

A Phase 2 trial conducted by Kythera Biopharmaceuticals evaluated a treatment for superficial lipomas; the study is completed and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lipoma

Drugs mentioned

• Investigational product (Kythera Biopharmaceuticals)

Snippet

Sponsor: Kythera Biopharmaceuticals | Conditions: Lipoma | Phase 2 | Status: COMPLETED | Results posted: 2016-01-14